18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer

被引：2
|
作者：
Meijer, Dennie [1 ]
Wondergem, Maurits [2 ]
Knol, Remco J. J. [2 ]
Broos, Wouter A. M. [2 ]
van der Zant, Friso M. [2 ]
机构：
[1] Amsterdam Univ Med Ctr, Locat VU Med Ctr, Dept Urol, Amsterdam, Netherlands
[2] Noordwest Ziekenhuisgrp, Dept Nucl Med, Location Alkmaar, Alkmaar, Netherlands
来源：
CLINICAL NUCLEAR MEDICINE | 2020年 / 45卷 / 02期
关键词：
F-18-DCFPyL PET/CT; prostate cancer; follicular lymphoma; MEMBRANE ANTIGEN; EXPRESSION;
D O I：
10.1097/RLU.0000000000002738
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-18-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-18-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-18-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.
引用
收藏
页码：E96 / E97
页数：2
相关论文
共 50 条
  • [31] Prostate Cancer Local Recurrence Detected With Both 18F-Fluciclovine and PSMA-targeted 18F-DCFPyL PET/CT
    Gorin, Michael A.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Rowe, Steven P.
    UROLOGY, 2017, 107 : E9 - E10
  • [32] Curative Therapy Choice and Lesion Detection by 18F-DCFPyL and Multiparametric MRI in Biochemically Recurrent Prostate Cancer
    Lindenberg, Liza
    Mena, Esther
    Turkbey, Baris
    Shih, Joanna
    Bergvall, Ethan
    Adler, Stephen
    Lin, Frank
    Ton, Anita
    McKinney, Yolanda
    Citrin, Deborah
    Madan, Ravi
    Dahut, William
    Choyke, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [33] Prostate Cancer Lymphangitic Pulmonary Carcinomatosis Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Potvin, Kylea
    Cho, Steve Y.
    Kim, Chun Ki
    Winquist, Eric
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 727 - 729
  • [34] Deep Learning for Automatic Prostate Segmentation On 18F-DCFPyL PET/CT In Prostate Cancer.
    Cysouw, M.
    Luining, W. I.
    de Vries, B. M.
    Oprea-Lager, D. E.
    Vis, A. N.
    Boellaard, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S732 - S732
  • [35] Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of 18F-DCFPyL PET/CT
    Civelek, A. Cahid
    RADIOLOGY, 2022, 303 (02)
  • [36] Solitary Prostate Carcinoma Penile Metastasis on 18F-DCFPyL PET/CT
    Chen, Jeffrey
    Russon, Andrew
    Mansberg, Victor
    Mansberg, Robert
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 78 - 80
  • [37] Reproducibility and Reliability of Radiomic Features in 18F-DCFPyL PET/CT Imaging of Prostate Cancer
    Ashrafinia, Saeed
    DiGianvittorio, Michael
    Rowe, Steven
    Gorin, Michael
    Lu, Lijun
    Lodge, Martin
    Pomper, Martin
    Allaf, Mohamad
    Rahmim, Arman
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [38] FDA Approves 18F-DCFPyL PET Agent in Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 11N - 11N
  • [39] Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18F-DCFPyl PET/CT
    Spinali, Keith L.
    Papke, David J.
    Shah, Hina J.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : E181 - E183
  • [40] Metastatic prostate cancer imaging with PSMA-directed 18F-DCFPyL PET/CT
    Hall, Andrew
    Rowe, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345